1. Pink Sheet
  2. >>Geography
  3. >>Europe

The Challenging Logistics Of Sending Medicine Donations To Ukraine

 
• By Ian Schofield

Parallel trading companies, which traditionally move medicines from low-priced to higher-priced markets across the EU, are getting involved in organizing donations of medical products to Ukraine.

panoramic view of Lviv Theatre of Opera and Ballet, Ukraine
Lviv is a staging post for deliveries of some medicines to Ukraine • Source: Alamy

As the conflict in Ukraine continues to escalate, European parallel traders are sending donations of critical medicines such as antibiotics and anesthetics across EU borders via Poland, Romania and Hungary.

Kasper Ernest, secretary of the parallel trader body, Affordable Medicines Europe, explained in an interview how the products were selected...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

US & EU Regulatory Support Growing For Animal Testing Alternatives, But Validation Remains A Hurdle

 
• By Eliza Slawther

In this first of a two-part series of articles, US Pharmacopeia CEO Ronald T. Piervincenzi tells the Pink Sheet how the use of alternatives to animal testing in drug development is gaining traction and discusses the challenges that exist.

AI And Inertia: The Disruptors Keeping EU Regulators Awake At Night

 
• By Francesca Bruce

Data is “the new oil,” but its use will challenge regulators, while inertia is the biggest disrupter of all for European regulators, according to European Medicines Agency chiefs past and present.

AI In Manufacturing: EU To Revamp GMP Guidance In Light Of Digital Advancements

 
• By Eliza Slawther

Pharma firms are being encouraged to respond to a European Commission consultation on planned updates to its good manufacturing practice standards which reflect the “rapid advancement” of modern technologies, like AI and digital systems, in drug manufacturing.

EU Health Chief Declares There Is No Better Alternative Than TEVs to Spark Antibiotic Innovation

 
• By Francesca Bruce

Clarity on what transferable exclusivity vouchers may look like for new antimicrobial drugs could be nearing. Denmark’s new presidency of the Council of the EU has prioritized concluding its negotiations with European Parliament over the legislative overhaul of the EU’s pharmaceutical legislation.

More from Geography